AMANDA PETTY: Open Payments
NPI 1174301386 · WAYCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,238 in 54 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $130 · 2025 $1,238
Food & beverage: $1,138Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $310 |
| UCB, Inc. | 14 | $292 |
| Janssen Biotech, Inc. | 9 | $288 |
| Mallinckrodt Hospital Products Inc. | 4 | $70 |
| Radius Health, Inc. | 2 | $50 |
| GENZYME CORPORATION | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Amgen Inc. | 2 | $32 |
| Organon LLC | 1 | $27 |
| Aurinia Pharma U.S., Inc. | 1 | $23 |
Products named: TREMFYA, Bimzelx, RINVOQ, SKYRIZI, ACTHAR, KEVZARA, SAPHNELO, EVENITY.
Industry payments across GA — which companies pay providers there.
